Tscan Therapeutics shares owned by Paradigm Biocapital Advisors
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Paradigm Biocapital Advisors
from 13F filings
Historical chart of Paradigm Biocapital Advisors investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Tscan Therapeutics by Paradigm Biocapital Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $2.1M | 354k | 5.85 |
More positions owned by Paradigm Biocapital Advisors
View all positions for Paradigm Biocapital Advisors